Navigation Links
Therapeutic hypothermia is promising strategy to minimize tissue damage

New Rochelle, NY, March 19, 2009Recognition of the benefits of cooling strategies to protect the brain and spinal cord after traumatic injury has led to a wealth of cutting edge research, prime examples of which are featured in a special hypothermia issue of Journal of Neurotrauma, a peer-reviewed journal published by Mary Ann Liebert, Inc. ( The issue will be available free online at

The issue includes a series of original articles presenting experimental and clinical evidence to support the use of modest hypothermia in specific conditions. These reports emanated from presentations at the 2nd International Brain Hypothermia Symposium and were selected for publication in the Journal by Guest Editors W. Dalton Dietrich, PhD, and M. Ross Bullock, MD, PhD, both from the University of Miami Miller School of Medicine and Patrick M. Kochanek, MD, from the University of Pittsburgh.

In his Introduction, Dr. Dietrich points out that many factors determine whether hypothermic therapy will be beneficial, including "how early hypothermic therapy is initiated after the insult, the duration of the hypothermic period, the degree of hypothermia, as well as the rewarming protocol. Thus, it is important that basic research studies are continuing in clinical relevant animal models to address these important questions."

The issue explores several aspects of hypothermia, including studies in animal models, its use in the operating room, and its role in the treatment of cardiac arrest, stroke and subarachnoid hemorrhage, traumatic brain (TBI) and spinal cord injury, and pediatric TBI and asphyxia.

Mackensen et al. focus on "Perioperative Hypothermia: Use and Therapeutic Implications," and Kim et al. describe "The Use of Pre-Hospital Mild Hypothermia After Resuscitation from Out-of-Hospital Cardiac Arrest." Kochanek et al. collaborate on two articles on therapeutic hypothermia in pediatric populations, one describing the Safar Vision, and the other focusing on applications in pediatric cardiac arrest. Shankaran presents "Neonatal Encephalopathy: Treatment with Hypothermia," and Bullock et al. provides an overview of "Current and Future Role of Therapeutic Hypothermia."


Contact: Vicki Cohn
Mary Ann Liebert, Inc./Genetic Engineering News

Related biology news :

1. Using evolution, UW team creates a template for many new therapeutic agents
2. The endocannabinoids: Functional roles and therapeutic opportunities
3. Potential new therapeutic molecular target to fight cancer
4. Galapagos and Cystic Fibrosis Foundation Therapeutics announce drug discovery collaboration
5. Methadone even at therapeutic levels can kill
6. Nucleonics initiates hepatitis B clinical trial with expressed interfering RNA therapeutic
7. Synthetic molecules may be less expensive alternative to therapeutic antibodies, researchers find
8. New technology enhances therapeutic potential of cord blood stem cells
9. Novel therapeutic strategy for colon cancer treatment
10. TG2 identified as potential therapeutic target in chemo-resistant ovarian cancer
11. Michael J. Fox Foundation awards $2.4M for validation of therapeutic targets for Parkinsons
Post Your Comments:
(Date:10/29/2015)... NEW YORK , Oct. 29, 2015 /PRNewswire/ ... wearable technology, announced a partnership with 2XU, a ... accessories, to deliver a smart hat with advanced ... runners and other athletes to monitor key biometrics ... of the strategic partnership, the two companies will bring ...
(Date:10/26/2015)... 26, 2015 ... adds Biometrics Market Shares, Strategies ... well as Emerging Biometrics Technologies: Global ... its collection of IT and Telecommunications ... --> . ...
(Date:10/23/2015)... California , October 23, 2015 ... (SMI) announce a mobile plug and play integration of ... real-world tasks SensoMotoric Instruments (SMI) present ... wearable solutions for eye tracking and physiological data registration. ... SMI Eye Tracking Glasses 2w and physiological ...
Breaking Biology News(10 mins):
(Date:11/27/2015)... , Nov. 27, 2015 /PRNewswire/--  Mallinckrodt plc ... announced today that it has closed the sale of ... to Guerbet (GBT- NYSE Euronext) in a transaction valued ... four manufacturing facilities and a total of approximately 1,000 ... the St. Louis area. This ...
(Date:11/25/2015)... 2015 --> ... - 2020 report analyzes that automating biobanking workflow ... in long-term samples, minimizing manual errors, improving the ... manual errors such as mislabeling or inaccurate sample ... plays a vital role in blood fractionation, DNA ...
(Date:11/25/2015)... DIEGO , Nov. 25, 2015  Neurocrine Biosciences, ... Kevin Gorman , President and CEO of Neurocrine Biosciences, ... Healthcare Conference in New York . ... to visit the website approximately 5 minutes prior to ... A replay of the presentation will be available on ...
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica Richman and ... early in their initial angel funding process. Now, they are paying it forward ... make early stage investments in the microbiome space. In this, they join ...
Breaking Biology Technology: